Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency

scientific article published in February 1994

Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/CS0860149
P698PubMed publication ID8143425

P2093author name stringRobertson D
O'Connor DT
Parmer RJ
Stone RA
Madrazo I
Biaggioni I
Langlais PJ
Cervenka JH
Levine GL
Franco-Bourland RE
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
cerebrospinal fluidQ54196
dopamineQ170304
P304page(s)149-158
P577publication date1994-02-01
P1433published inClinical ScienceQ372419
P1476titleDopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency
P478volume86

Reverse relations

cites work (P2860)
Q46266113A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
Q44781235A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease
Q28370470A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia
Q57810465ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal DOPAMINE-β-HYDROXYLASE
Q46121127Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus
Q37024972Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease
Q86545334Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia
Q64860747Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis
Q47766795Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship
Q34326431Dopamine beta hydroxylase genotype identifies individuals less susceptible to bias in computer-assisted decision making
Q33155329Dopamine-beta-hydroxylase in postural tachycardia syndrome
Q41609869Genetic diseases of hypotension.
Q28208179Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression
Q37634353Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.
Q40220042Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans
Q37001062Human Dopamine -Hydroxylase Promoter Variant Alters Transcription in Chromaffin Cells, Enzyme Secretion, and Blood Pressure
Q33813029Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure
Q35747291Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology
Q35632312Human phenotypes and animal knockout models of genetic autonomic disorders
Q44921069Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility
Q28236071Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia
Q45714519Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency
Q34685511Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase
Q37771075Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment
Q93164939The Noradrenergic System in Parkinson's Disease
Q34463158The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.

Search more.